Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06451003 · ClinicalTrials.gov registry record · NA

Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery

A NA study of Cancer and Surgery, sponsored by Medical University of South Carolina.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06451003 is a NA study of Cancer and Surgery that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 30 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06451003, a NA study of Cancer and Surgery, is actively recruiting participants, sponsored by Medical University of South Carolina.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

While blood clots after major cancer surgery are common and harmful to patients, the medications to decrease blood clot risk are seldom used after patients leave the hospital despite the recommendation of multiple professional medical societies. The reason why these medications are seldom prescribed is not well understood. The main questions this study aims to answer are: * Does surgeon education paired with an electronic medical record based decision support tool improve the guideline concordant prescription of pharmacologic venous thromboembolism after abdominopelvic cancer surgery? * Does dedicated patient education regarding blood clots at the time of hospital discharge after abdominopelvic cancer surgery improve understanding of the risk of venous thromboembolism and adherence to pharmacologic prophylaxis? The investigators will study these questions using a stepped-wedge randomized trial where groups of surgeons will use a tool integrated to the electronic medical record to educate them on the individualized patient risks of blood clots after major cancer surgery and inform them regarding guidelines for preventative medicines. Utilization of the medications before and after using the tool will be compared. Patients will be administered a questionnaire assessing their awareness of blood clots as a risk after cancer surgery. For those prescribed medications to reduce blood clot risk after leaving the hospital, the questionnaire will evaluate whether they took the medications as prescribed. Survey results will be evaluated before and after implementation of education on blood clot risk at the time of hospital discharge.

Interventions

  • BEHAVIORAL Exposure to clinical decision support system and education

Study Locations (1)

South Carolina

  • Medical University of South Carolina - Charleston

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2024-07-01
Est. Completion 2026-12-31
Phase NA

What the Registry Record Tells You About NCT06451003

The ClinicalTrials.gov registry entry for NCT06451003 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Exposure to clinical decision support system and education is the first listed.

NCT06451003 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.

Frequently Asked Questions

What is clinical trial NCT06451003 about?

NCT06451003 is a clinical study titled "Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery". While blood clots after major cancer surgery are common and harmful to patients, the medications to decrease blood clot risk are seldom used after patients leave the hospital despite the recommendation of multiple professional medical societies. The reason why these medications are seldom prescribed...

What is the current status of trial NCT06451003?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-07-01. Estimated completion is 2026-12-31.

What conditions does trial NCT06451003 study?

This clinical trial studies the following conditions: Cancer, Surgery, Pulmonary Embolism, Venous Thromboembolism, Deep Vein Thrombosis.

What interventions are being tested in trial NCT06451003?

The interventions under investigation include: Exposure to clinical decision support system and education (BEHAVIORAL).

Who is sponsoring clinical trial NCT06451003?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06451003 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.